Shenzhen YHLO Biotech (688575) Stock Overview

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers automatic chemiluminescence immunoassay analyzers, chemiluminescent immunoassay analyzers, and iModule automatic immunoassay pipelines; and automatic immunofluorescence staining systems, automatic immunofluorescence analysis systems, automatic western blotting analyzers, auto automatic western blot analyzers, and automatic western blotting instruments. It also provides UNION new generation immune analyzers; dry fluorescence immunoassay analyzers, vision automatic dynamic ESR analyzers, and vision dynamic ESR analyzers; and automated sample processing systems and intelligent laboratory information systems, as well as antigen detection and test kits. Shenzhen YHLO Biotech Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.